Latest Brain tumor Stories
Trial Progressing On Track; BETHESDA, Md., Aug.
Recent studies have shown that transplanting induced pluripotent stem cell-derived neural stem cells (iPS-NSCs) can promote functional recovery after spinal cord injury in rodents and non-human primates.
NuvOx Pharma, a Tucson based biotechnology company, began a Phase Ib clinical trial of its new drug NVX-108 in patients with glioblastoma, a deadly form of brain cancer. Tucson,
POINT ROBERTS, Wash. and NEW YORK, Aug.
New research at Washington University School of Medicine in St. Louis helps explain why brain tumors occur more often in males and frequently are more harmful than similar tumors in females.
- Results from Phase I program in glioblastoma multiforme presented at ASCO earlier this year NORTH CHICAGO, Ill., Aug.
The ANS Skull Base Surgery Center offers hope for patients who suffer from brain tumors, acoustic neuromas, pituitary tumors, skull base meningiomas, trigeminal neuralgia, spinal fluid leaks,
With the rising popularity of “boutique surgeries” being offered by less qualified specialists, ANS has launched an awareness campaign to educate the community on the importance of choosing
Article in "Neurosurgery" describes how RapidArc Radiosurgery treatments can be specially optimized to treat multiple brain metastases at the same time PALO ALTO, Calif., July 30,
National Brain Tumor Society connects biotech company to researchers’ technology. Hershey, PA & Boston, MA (PRWEB) July 28, 2014 Immunomic Therapeutics,
- totally perplexed and mixed up.